Press release
Human Chorionic Gonadotropin (HCG) Market 2026 By Major Key Players - Merck & Co., EMD Sereno, Fresenius Kabi
Human Chorionic Gonadotropin
Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1011
According to Centers of Disease Control and Prevention (CDC) in 2016, approximately 7.3 million women aged 15 - 44 have used infertility services. Moreover, 6.7% of the married women aged 15 - 44 were reported infertile. According to Azura Vascular Care, around 17% of the couples in the U.S. deal with infertility out of which 30% cases are a result of male infertility. These numbers suggests significant demand for infertility treatments, such as HCG in order for females to conceive a child. According to a statistical survey conducted by HealthGrove, pituitary gland disorders resulted into the death of around 205 people in 2015, out of which highest percentage belonged to white men. Pituitary disorders resulting into significant mortality rate are propelling the demand for human chorionic gonadotropin hormone.
Additionally, various other factors such as endometriosis, hormonal imbalance, polycystic ovary syndrome, and others are expected to propel the growth of global HCG market. For instance, according to Frisco Institute of Reproductive Medicine, around 10% of women of reproductive age in the U.S. suffer from polycystic ovary syndrome. However, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.
Market Taxonomy:
The global human chorionic gonadotropin by Coherent Market Insights is segmented on the basis of Technology, Therapeutic area, and end user.
On the basis of technology, the global human chorionic gonadotropin is segmented as:
Natural Source Extraction
Recombinant DNA Technology
On the basis of therapeutic area, the global human chorionic gonadotropin market is segmented as:
Female infertility treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
On the basis of end user, the global human chorionic gonadotropin market is segmented as:
Fertility Centers
Research Institutes
Others
North America to dominate global human chorionic gonadotropin (HCG) market, owing to rising frequency of infertility cases
On the basis of geography, the global human chorionic gonadotropin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the highest regional contributor to the market and is expected to continue as a regional dominator over the forecast years. This primarily owes to the rising number of infertility cases as well as hormonal dysfunction among young males and females as a result of changing lifestyle.
Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1011
The key players operating the global human chorionic gonadotropin market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: https://www.coherentwire.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Chorionic Gonadotropin (HCG) Market 2026 By Major Key Players - Merck & Co., EMD Sereno, Fresenius Kabi here
News-ID: 1467807 • Views: …
More Releases from Coherent Market Insights - Pharmaceutical Industry
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data.
Ask For Sample Copy of Research…
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.
Ask For a Sample Copy of This Business Report @…
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players.
Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976
Market…
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around…
More Releases for HCG
Physicians Certified at the IAPAM's hCG Training are True hCG Experts
Las Vegas, Nevada, USA - June 8, 2012 -- The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG diet program, and graduates of the IAPAM's hCG Training are…
Graduates of the IAPAM's hCG Training are True hCG Experts
The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG for weight loss program, and graduates of the IAPAM's hCG Training are launching the most successful hCG Clinics in…
Graduates of the IAPAM's hCG Training are True hCG Experts
The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG for weight loss program, and graduates of the IAPAM's hCG Training are launching the most successful hCG Clinics in…
Glenmore Healthcare's hCG Program is Consistent with Dr. Oz's hCG Principles
Calgary, Alberta, June 30, 2011 -- The core principles of Glenmore Healthcare's hCG for Weight Loss Program are consistent with those outlined by Dr. Oz in his interview for First for Women magazine's June 27th issue: it is imperative for patients to undertake an hCG program under the care of a trained physician, and never use hCG (homeopathic hCG) that is sold without a prescription.
In his recent interview in the…
With hCG 1234, Creative Bioscience Launches the Next Generation of Dietary Suppl …
With its already successful hCG 1234 product, Creative Biosicence launches its next generation of hCG dietary supplements: health Conscious Group Zero, LLC ("hCG Zero").
Creative Bioscience has carefully listened to clients, applied clinical research, and taken Dr. Simeon's guidelines to the next level. The result is a new era in the dietary supplement industry: hCG Zero.
Creative Bioscience has formulated all hCG Zero products as dietary supplement drops. hCG Zero is comprised…
IAPAM's hCG Directory Helps Consumers Find Expert hCG Physicians
The International Association for Physicians in Aesthetic Medicine offers patients a NEW hCG Diet Clinic listing of physicians in their area, who have been expertly trained in hCG for weight loss by the IAPAM.
Las Vegas, NV, May 17, 2011 -- The IAPAM's NEW hCG Diet Listing (http://www.iapam.com/aesthetic-resources/hcg-diet-clinics) provides consumers with a comprehensive listing of qualified IAPAM trained hCG Physicians. Patients seeking out certified physicians, who have completed the IAPAM’s hCG…
